Stacking as a key property for creating nanoparticles with tunable shape: The case of Squalenoyl-doxorubicin

Archive ouverte

Mougin, Julie | Yesylevskyy, Semen | Bourgaux, Claudie | Chapron, David | Michel, Jean-Philippe | Dosio, Franco | Stella, Barbara | Ramseyer, Christophe | Couvreur, Patrick

Edité par CCSD ; American Chemical Society -

International audience. The development of elongated nanoparticles for drug delivery is of growing interest in recent years, due to longer blood circulation and improved efficacy compared to spherical counterparts. Squalenoyl-doxorubicin (SQ-Dox) conjugate was previously shown to form elongated nanoparticles with improved therapeutic efficacy and decreased toxicity compared to free doxorubicin. By using experimental and computational techniques, we demonstrate here that the specific physical properties of SQ-Dox, which include stacking and electrostatic interactions of doxorubicin as well as hydrophobic interactions of squalene, are involved in the formation of nanoassemblies with diverse elongated structures. We show that SQ-Dox bioconjugate concentration, ionic strength, and anion nature can be used to modulate the shape and stiffness of SQ-Dox nanoparticles. As those parameters are involved in nanoparticle behavior in biological media, these findings could bring interesting opportunities for drug delivery and serve as an example for the design of original nanodrugs with stacking properties tuned for particular clinical purposes.

Suggestions

Du même auteur

A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity

Archive ouverte | Maksimenko, Andrei | CCSD

International audience. We identified that the chemical linkage of the anticancer drug doxorubicin onto squalene, a natural lipid precursor of the cholesterol’s biosynthesis, led to the formation of squalenoyl doxor...

Low density lipoproteins and human serum albumin as the carriers of squalenoylated drugs: insights from molecular simulations

Archive ouverte | Ramseyer, Christophe | CCSD

International audience

Low-Density Lipoproteins and Human Serum Albumin as Carriers of Squalenoylated Drugs: Insights from Molecular Simulations

Archive ouverte | Yesylevskyy, Semen | CCSD

International audience. We have studied the interaction of three clinically promising squalenoylated drugs (gemcitabine-squalene, adenine-squalene, and doxorubicin-squalene) with low-density lipoproteins (LDL) by me...

Chargement des enrichissements...